|
| |
Retinitis PigmentosaDownload PDF containing detailed information.
Recent Publications on Retinitis Pigmentosa: |  |
Refractive surgery in patients with retinitis pigmentosa.
Purpose. To evaluate the refractive outcomes and safety of laser... | 20th November, 2009
| Department of Ophthalmology, A. Fiorini Hospital, Terracina, University of
| Eur J Ophthalmol. 2009 Nov 3.
|
Expression and structural characterization of peripherin/RDS, a membrane protein implicated in photoreceptor outer segment morphology.
Peripherin/RDS is a member of the tetraspanin family of integral membrane... | 19th November, 2009
| The Marie Curie Laboratory for Membrane Proteins, National University of
| Eur Biophys J. 2009 Nov 18.
DOI Direct Link |
Molecular Mechanisms of Rhodopsin Retinitis Pigmentosa and the Efficacy of Pharmacological Rescue.
Variants of rhodopsin, a complex of 11-cis retinal and opsin, cause... | 17th November, 2009
| Department of Ophthalmology and the Charlie Mack Overstreet Laboratories
| J Mol Biol. 2009 Nov 10.
DOI Direct Link |
Rescue of photoreceptors by BDNF gene transfer using in vivo electroporation in the RCS rat of retinitis pigmentosa.
PURPOSE: To investigate the feasibility of introducing brain-derived... | 17th November, 2009
| Department of Ophthalmology, Eye and ENT Hospital, Fudan University,
| Curr Eye Res. 2009 Sep;34(9):791-9.
|
Artificial vision by direct optic nerve electrode (AV-DONE) implantation in a blind patient with retinitis pigmentosa.
The purpose of this study was to evaluate the efficacy and safety of... | 7th November, 2009
| Department of Ophthalmology, Osaka University Medical School, Suita,
| J Artif Organs. 2009;12(3):206-9. Epub 2009 Sep 19.
DOI Direct Link |
→View more research publications. |
Press Releases About Retinitis Pigmentosa:
|
 |
| R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021 |
25th August, 2009 |
R-Tech Ueno, Ltd. |
TOKYO, Aug. 25 /PRNewswire/ -- We are pleased to announce that subject enrollment for the phase 2 clinical study of 0.15% UF-021 (generic name; isopropyl unoprostone; active ingredient of Rescula(R)
|
| Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors |
28th May, 2009 |
Neurotech Pharmaceuticals, Inc. |
LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical
|
| QLT announces completion of Phase Ia safety trial of its synthetic retinoid product |
12th March, 2009 |
QLT Inc. |
VANCOUVER, March 12 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the results from a Phase Ia trial of QLT091001 in healthy
|
| New Year Brings New Hope to Children Born With Cleft Lip, Palate |
7th January, 2009 |
American Society of Plastic Surgeons |
Plastic Surgeons Kick-Off 2009 with Mission Trips to Developing Countries
ARLINGTON HEIGHTS, Ill., Jan. 7 /PRNewswire-USNewswire/ -- Parents of a child born with cleft lip and palate often have one
|
| Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island |
21st October, 2008 |
|
CUMBERLAND, Rhode Island, October 21 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company
focused on the development of sight-saving therapeutics for chronic retinal
|
Companies working in the area of Retinitis Pigmentosa from Bioportfolio's Biocorporate database : | |
| Company Name | |
Second Sight, located in Sylmar, California, was founded in 1998 to create a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa and...
www.2-sight.com/ View full profile
| |
Acucela Inc. is a biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and...
www.acucela.com/ View full profile
| |
Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new...
www.neurotechusa.com/ View full profile
| | →View more Retinitis Pigmentosa related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Retinitis Pigmentosa scientists - we have details of around 584 individuals working on Retinitis Pigmentosa .
This page has been viewed 1117 times
Recent Search Terms used to find this page: retinitis-pigmentosa 2009 | retinitis-pigmentosa news 19th nov 2009 | retinitis pigmentosa reaserch nov 2009 | recent developments in retinitis pigmentosa | recent medical news on retinitis pigmentosa | Retinitis Pigmentosa research 2009 | latest research for retinitis pigmentosa november 2009 | QLT retinitis | retinitis pigmentosa research companies | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Retinitis Pigmentosa across BioPortfolio, or for Retinitis Pigmentosa Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
